Hinge Health, Inc. Class A (HNGE) Price & Analysis

Compare

114 Followers

HNGE Stock Chart & Stats

Day’s Range― - ―

52-Week Range$33.42 - $62.00

Previous Close$36.79

Volume525.07K

Average Volume (3M)895.88K

Market Cap

$4.72B

Enterprise Value$3.83B

Total Cash (Recent Filing)$413.26M

Total Debt (Recent Filing)$9.97M

Price to Earnings (P/E)27.7

Beta0.86

Next Earnings

Aug 05, 2025

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)N/A

Shares Outstanding24,749,540

10 Day Avg. Volume836,094

30 Day Avg. Volume895,884

Financial Highlights & Ratios

PEG Ratio0.00

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market Cap0.81

Enterprise Value/Revenue14.58

Enterprise Value/Gross Profit19.36

Enterprise Value/Ebitda-6.84

Forecast

1Y Price Target

$56.62

Price Target Upside-6.18% Downside

Rating ConsensusStrong Buy

Number of Analyst Covering14

Bulls Say, Bears Say

Bulls Say

Financial PerformanceHinge Health reported strong second-quarter results, the company’s first quarter as a public company following its June IPO.

Revenue GrowthRevenue of $139.1 million easily exceeded the $125.4 million Street estimate, primarily due to higher-than-anticipated eligible lives.

Bears Say

Near-Term Financial ImpactThe financial impact near-term is minimal; however, HingeSelect should begin contributing to revenue growth and EBITDA in 2027.

Risk FactorsKey risks for Hinge Health include reliance on key distribution partners such as health plans and PBMs.

Hinge Health, Inc. Class A News

Hinge Health price target raised to $65 from $45 at Raymond James

Raymond James raised the firm’s price target on Hinge Health (HNGE) to $65 from $45 and keeps an...

2d ago

HNGE

Hinge Health price target raised to $59 from $47 at Needham

Needham raised the firm’s price target on Hinge Health (HNGE) to $59 from $47 and keeps a Buy...

2d ago

HNGE

Hinge Health price target raised to $62 from $48 at Truist

Truist raised the firm’s price target on Hinge Health (HNGE) to $62 from $48 and keeps a Buy...

2d ago

HNGE

Hinge Health price target raised to $63 from $55 at Stifel

Stifel analyst David Grossman raised the firm’s price target on Hinge Health (HNGE) to $63 from $55 and...

2d ago

HNGE

Video: Disney, McDonald’s and Uber headline busy earnings slate

The Fly has brought its to-the-moment stock market reporting to YouTube! Subscribe if you want to know how...

2d ago

AMD

DIS

Hinge Health price target raised to $64 from $42 at BofA

BofA raised the firm’s price target on Hinge Health (HNGE) to $64 from $42 and keeps a Buy...

2d ago

HNGE

Hinge Health price target raised to $57 from $46 at Morgan Stanley

Morgan Stanley analyst Craig Hettenbach raised the firm’s price target on Hinge Health (HNGE) to $57 from $46...

3d ago

HNGE

Hinge Health price target raised to $61 from $52 at Canaccord

Canaccord raised the firm’s price target on Hinge Health (HNGE) to $61 from $52 and keeps a Buy...

3d ago

HNGE

Hinge Health reports Q2 EPS ($13.10) vs (96c) last year

Reports Q2 revenue $139.1M, consensus $125.34M. “In Q2 we delivered year-over-year revenue growth of 55% and a strong...

3d ago

HNGE

Hinge Health sees Q3 revenue $141M-$143M, consensus $128.83M

Sees Q3 adjusted income from operations $17M-$21M. Published first on TheFly – the ultimate source for real-time, market-moving...

3d ago

HNGE

Hinge Health’s Strategic Growth and Market Positioning: A Buy Recommendation by Ryan MacDonald

Needham analyst Ryan MacDonald maintained a Buy rating on Hinge Health, Inc. Class A today and set a...

2d ago

HNGE

Hinge Health’s Strong Growth and Margin Improvements Drive Buy Rating and Increased Price Objective

Analyst Bradley Sills of Bank of America Securities reiterated a Buy rating on Hinge Health, Inc. Class A,...

2d ago

HNGE

Hinge Health Reports Strong Q2 2025 Growth

Hinge Health, Inc. Class A ( ($HNGE) ) has released its Q2 earnings. Here is a breakdown of...

3d ago

HNGE

Hinge Health Reports Strong Q2 2025 Revenue Growth

Hinge Health, Inc. Class A ( ($HNGE) ) has shared an update. On August 5, 2025, Hinge Health...

3d ago

HNGE

HNGE FAQ

What was Hinge Health, Inc. Class A’s price range in the past 12 months?

Hinge Health, Inc. Class A lowest stock price was $33.42 and its highest was $62.00 in the past 12 months.

What is Hinge Health, Inc. Class A’s market cap?

Hinge Health, Inc. Class A’s market cap is $4.72B.

When is Hinge Health, Inc. Class A’s upcoming earnings report date?

Hinge Health, Inc. Class A’s upcoming earnings report date is Aug 05, 2025 which is 3 days ago.

How were Hinge Health, Inc. Class A’s earnings last quarter?

Hinge Health, Inc. Class A released its earnings results on Aug 05, 2025. The company reported $0.349 earnings per share for the quarter, beating the consensus estimate of $0.086 by $0.263.

Is Hinge Health, Inc. Class A overvalued?

According to Wall Street analysts Hinge Health, Inc. Class A’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Hinge Health, Inc. Class A pay dividends?

Hinge Health, Inc. Class A does not currently pay dividends.

What is Hinge Health, Inc. Class A’s EPS estimate?

Hinge Health, Inc. Class A’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Hinge Health, Inc. Class A have?

Hinge Health, Inc. Class A has 24,749,540 shares outstanding.

What happened to Hinge Health, Inc. Class A’s price movement after its last earnings report?

Hinge Health, Inc. Class A reported an EPS of $0.349 in its last earnings report, beating expectations of $0.086. Following the earnings report the stock price went up 25.57%.

Which hedge fund is a major shareholder of Hinge Health, Inc. Class A?

Currently, no hedge funds are holding shares in HNGE

Hinge Health, Inc. Class A Stock Smart Score

Neutral

Company Description

Hinge Health, Inc. Class A

Hinge Health, Inc. Class A (HNGE) is a digital health company specializing in musculoskeletal (MSK) care solutions. The company operates in the health technology sector, providing innovative treatment programs that combine wearable sensors, software, and services to manage chronic musculoskeletal conditions such as back and joint pain. Hinge Health’s core offerings include personalized exercise therapy, behavioral health support, and access to expert physical therapy consultations, aiming to improve patient outcomes and reduce healthcare costs for employers and health plans.

Hinge Health, Inc. Class A (HNGE) Earnings & Revenues

Historic Earnings Reports

HNGE Company Deck

HNGE Earnings Call

Q2 2025

0:00 / 0:00

HNGE Stock 12 Month Forecast

Average Price Target

$56.62

▼(-6.18% Downside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"39":"$39","66":"$66","45.75":"$45.8","52.5":"$52.5","59.25":"$59.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":65,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$65.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":56.62,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$56.62</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":41,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$41.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[39,45.75,52.5,59.25,66],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Mar<br/>2025","9":"Jun<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,44.95,46.4923076923077,48.034615384615385,49.57692307692308,51.11923076923077,52.66153846153846,54.20384615384616,55.746153846153845,57.28846153846154,58.830769230769235,60.37307692307692,61.91538461538462,63.45769230769231,{"y":65,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,44.95,45.84769230769231,46.745384615384616,47.643076923076926,48.54076923076923,49.43846153846154,50.33615384615385,51.23384615384615,52.13153846153846,53.029230769230765,53.926923076923075,54.824615384615385,55.72230769230769,{"y":56.62,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,44.95,44.64615384615385,44.34230769230769,44.03846153846154,43.73461538461539,43.43076923076923,43.12692307692308,42.823076923076925,42.519230769230774,42.215384615384615,41.91153846153846,41.60769230769231,41.30384615384615,{"y":41,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":40.16,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.16,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.16,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.16,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.16,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.16,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.16,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.16,"date":1743465600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.16,"date":1746057600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.45,"date":1748736000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":40.45,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.31,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":44.95,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 29,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >